Amino Acid Composition Restores Liver Metabolism
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Liver diseases such as alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) pose significant global health challenges due to chronic inflammation, fat accumulation, and potential progression to cirrhosis and cancer, with existing treatments lacking effective solutions for restoring altered amino acid metabolism.
Innovation Solution
A composition comprising specific amino acids (leucine, isoleucine, valine, threonine, lysine) combined with carboxylic acids (citric acid, succinic acid, malic acid) is administered to treat liver diseases, effectively restoring altered amino acid metabolism and preventing autophagy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If amino acid supplementation is used to treat liver diseases, then altered amino acid metabolism is restored, but the complexity of treatment composition increases
Solution Approach 1:
The treatment composition is segmented into distinct functional components: branched-chain amino acids (leucine, isoleucine, valine) as core therapeutic agents, and aromatic amino acids (phenylalanine, tyrosine, tryptophan) as supplementary components. This segmentation allows for targeted restoration of amino acid metabolism while maintaining compositional clarity and therapeutic focus.
Solution Approach 2:
The amino acid composition serves multiple therapeutic functions simultaneously: it restores altered amino acid metabolism, provides substrate for protein synthesis, supports mitochondrial function, and addresses nutritional deficiencies. This multi-functionality reduces the need for multiple separate treatments, thereby managing overall treatment complexity.
2Reliability
If specific amino acid compositions are administered to restore metabolism, then therapeutic effectiveness improves, but the difficulty of precise formulation increases
Solution Approach 1:
The formulation specifies precise parameter ranges for amino acid concentrations and ratios, particularly for branched-chain to aromatic amino acid ratios. These parameter changes are optimized to achieve therapeutic effectiveness while providing a formulation window that balances precision requirements with manufacturing feasibility.
Solution Approach 2:
The treatment employs a composite amino acid formulation combining multiple amino acid types in specific ratios. This composite approach integrates branched-chain and aromatic amino acids into a single therapeutic agent, simplifying the formulation process while maintaining the precision needed for metabolic restoration.
3Reliability
If amino acid therapy is used to treat liver diseases, then patient outcomes improve, but the cost of treatment increases
Solution Approach 1:
The therapy extracts and prioritizes the most therapeutically relevant amino acids (branched-chain amino acids) that directly address the metabolic dysfunction in liver disease. By focusing on these key components rather than providing complete amino acid profiles, the treatment achieves therapeutic outcomes while reducing overall treatment cost.
Solution Approach 2:
The amino acid formulation uses readily available, cost-effective amino acid sources that can be synthesized or obtained from conventional protein hydrolysis. These amino acids serve as disposable nutritional substrates that are metabolized and replenished regularly, providing sustained therapy at manageable costs.
Data Source
AI summary
Composition for use in the prevention and/or treatment of a liver disease in a mammal, the composition comprising an active agent, said active agent containing the amino acids leucine, isoleucine, valine, threonine, lysine and the carboxylic acids citric acid, succinic acid, malic acid.